Central nervous system depressants gamma-hydroxybutyrate

This is a central nervous system depressant licensed for the treatment of narcolepsy with cataplexy. At recommended doses, it has been associated with confusion, depression and other neuropsychiatric effects. Sodium oxybate is related to gamma hydroxybutyrate, a known drug of abuse, which has been associated with seizures, respiratory depression, coma and death. 

Gamma hydroxybutyrate, or GHB, is another popular club drug. It is a central nervous system depressant, which means that it slows down the functioning of the brain and nerves. GHB users feel sedated, sleepy, or sometimes euphoric. GHB can be taken in the form of tablets, a powder, or a liquid. 

GHB, short for its chemical name gamma hydroxybutyrate, is a potent sedative and a depressant of the central nervous system. GHB was first synthesized in the 1920s, although it was not specifically designed to mimic another existing drug. In the 1960s, GHB was developed for possible use as an anesthetic. However, the makers of GHB later withdrew it from consideration for approval by the U.S. FDA because of severe side effects reported by patients. 

GHB is short for gamma hydroxybutyrate. The form used as a club drug is a powerful, synthetically produced depressant that affects the central nervous system. However, GHB also exists naturally in the body. It is produced in the brain by a neurotransmitter called gamma-aminobutyric acid (GABA). GHB is found in several parts of the human brain, particularly the thalamus, the hypothalamus, and the substantia nigra. 

---